Free Trial

Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume

Evaxion Biotech A/S logo
$2.71 -0.38 (-12.30%)
As of 01/21/2025 04:00 PM Eastern

Evaxion Biotech A/S Short Interest Data

Evaxion Biotech A/S (EVAX) has a short interest of 980,100 shares. This marks a 709.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 104,380 shares to cover all short positions.

Current Short Interest
980,100 shares
Previous Short Interest
121,100 shares
Change Vs. Previous Month
+709.33%
Dollar Volume Sold Short
$4.14 million
Short Interest Ratio
2.9 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
1,170,000 shares
Percentage of Shares Shorted
83.77%
Today's Trading Volume
165,071 shares
Average Trading Volume
104,380 shares
Today's Volume Vs. Average
158%
Short Selling Evaxion Biotech A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EVAX Short Interest Over Time

EVAX Days to Cover Over Time

EVAX Percentage of Float Shorted Over Time

Evaxion Biotech A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2024980,100 shares $4.14 million +709.3%N/A2.9 $4.23
12/15/2024121,100 shares $138,054.00 +285.7%N/A2 $1.14
11/30/202431,400 shares $52,124.00 -12.8%N/A0.6 $1.66
11/15/202436,000 shares $53,280.00 -31.6%N/A0.7 $1.48
10/31/202452,600 shares $137,812.00 -22.0%N/A1.1 $2.62
10/15/202467,400 shares $181,306.00 -21.1%N/A1.4 $2.69
9/30/202485,400 shares $265,594.00 +286.4%N/A1.7 $3.11
9/15/202422,100 shares $66,300.00 -35.2%N/A0.6 $3.00
8/31/202434,100 shares $104,005.00 -24.9%N/A0.8 $3.05
8/15/202445,400 shares $135,746.00 +9.4%N/A1.1 $2.99
7/31/202441,500 shares $118,690.00 -20.4%N/A1.1 $2.86
7/15/202452,100 shares $164,115.00 -40.8%N/A1.4 $3.15
6/30/202488,000 shares $255,200.00 +93.8%N/A2.3 $2.90
6/15/202445,400 shares $140,740.00 +6.3%N/A1 $3.10
5/31/202442,700 shares $156,709.00 -10.9%N/A1.5 $3.67
5/15/202447,900 shares $180,104.00 -10.0%N/A1.4 $3.76
4/30/202453,200 shares $222,908.00 +11.3%N/A1 $4.19
4/15/202447,800 shares $195,980.00 +12.2%N/A0.1 $4.10
3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20
3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99
2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60
2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15
1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93
1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99
12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69
12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66
11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80
11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75
10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12
10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85
9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83
9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75
8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83
8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01
7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24
7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26
6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30
6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30
5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52
5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57
A deadly mistake in my prediction… (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26
4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.56
3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13
3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08
2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54
2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57
1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61
1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55
12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78
12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00
11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18
11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36
10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60
10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92
9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63
9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06
8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35
8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93
7/31/2022194,600 shares $595,476.00 +6.5%N/A0.5 $3.06
7/15/2022182,700 shares $442,134.00 -9.8%N/A0.5 $2.42
6/30/2022202,600 shares $388,992.00 +13.1%N/A0.5 $1.92
6/15/2022179,100 shares $300,888.00 +3.0%N/A0.5 $1.68
5/31/2022173,900 shares $340,844.00 -35.6%N/A0.5 $1.96
5/15/2022270,100 shares $469,974.00 +4,810.9%N/A0.7 $1.74
4/30/20225,500 shares $15,400.00 -41.5%N/A0.2 $2.80
4/15/20229,400 shares $27,072.00 -34.7%N/A0.2 $2.88
3/31/202214,400 shares $43,632.00 +84.6%N/A0.2 $3.03
3/15/20227,800 shares $20,826.00 +116.7%N/A0.1 $2.67
2/28/20223,600 shares $10,944.00 -82.0%N/A0 $3.04
2/15/202220,000 shares $63,800.00 -58.6%N/A0.1 $3.19
1/31/202248,300 shares $151,662.00 -3.0%N/A0.2 $3.14
1/15/202249,800 shares $203,682.00 +28.7%N/A0 $4.09
12/31/202138,700 shares $171,054.00 +25.7%N/A0 $4.42
12/15/202130,800 shares $126,588.00 +37.5%N/A0 $4.11
11/30/202122,400 shares $104,384.00 -57.1%N/A0 $4.66
11/15/202152,200 shares $324,162.00 +78.2%N/A0.1 $6.21
10/29/202129,300 shares $222,973.00 +229.2%N/A0 $7.61
10/15/20218,900 shares $70,488.00 -77.2%N/A0.1 $7.92
9/30/202139,000 shares $375,960.00 -27.9%N/A0.4 $9.64
9/15/202154,100 shares $444,161.00 +57.7%N/A0.6 $8.21
8/31/202134,300 shares $223,979.00 -2.8%N/A0.3 $6.53
8/13/202135,300 shares $205,093.00 No ChangeN/A0.5 $5.81

EVAX Short Interest - Frequently Asked Questions

What is Evaxion Biotech A/S's current short interest?

Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 980,100 shares of EVAX short. Learn More on Evaxion Biotech A/S's current short interest.

What is a good short interest ratio for Evaxion Biotech A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVAX shares currently have a short interest ratio of 3.0. Learn More on Evaxion Biotech A/S's short interest ratio.

Is Evaxion Biotech A/S's short interest increasing or decreasing?

Evaxion Biotech A/S saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 980,100 shares, an increase of 709.3% from the previous total of 121,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Evaxion Biotech A/S's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evaxion Biotech A/S: MIRA Pharmaceuticals, Inc. (5.38%), BioXcel Therapeutics, Inc. (1.63%), Cyclo Therapeutics, Inc. (0.72%), Aprea Therapeutics, Inc. (0.23%), Bullfrog AI Holdings, Inc. (4.12%), Carisma Therapeutics, Inc. (2.46%), MEI Pharma, Inc. (0.20%), Affimed (5.71%), Pieris Pharmaceuticals, Inc. (1.82%), BriaCell Therapeutics Corp. (4.17%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Evaxion Biotech A/S stock?

Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading down $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evaxion Biotech A/S?

A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further.

How often is Evaxion Biotech A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:EVAX) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners